series-a
Stage
2020
Founded
1
Investors
About
Sorriso Pharmaceuticals is a development-stage biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory diseases.
Explore Sorriso Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.